The Therapeutic Goods
Administration is inviting comments
on a proposal to amend the
Schedule 2 entry for Naproxen to
include a modified release dosage
form of 600mg or less of the
medication per dosage unit in packs
of 16 or less, when not labelled for
the treatment of children under 12
years of age.
Also up for consideration is a
proposal to include sodium oxbyate
for human therapeutic use in
Schedule 8.
The matters are on the agenda
for the Mar 2014 meeting of the
Advisory Committee on Medicines
Scheduling, with comments sought
in electronic form by 19 Dec 2013
to SMP@health.gov.au.The above article was sent to subscribers in Pharmacy Daily's issue from 22 Nov 13 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 22 Nov 13
THE Pharmaceutical Society of Australia (PSA) awarded Brooke Shelly the prestigious 2024 PSA MIMS Credentialed Pharmacist of the Year award last Fri at the Credentialed Pharmacist Conference (CPC24) (PD breaking news).
THE Pharmaceutical Society of Australia (PSA) has unveiled a comprehensive membership package designed to provide robust support for credentialed pharmacists throughout their professional journey.
MEDICAL research produces better outcomes when people with lived experience are involved in the process, according to Breast Cancer Network Australia (BCNA).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.